Skip to main content
. Author manuscript; available in PMC: 2010 Nov 1.
Published in final edited form as: Mol Cancer Ther. 2010 May;9(5):1219–1233. doi: 10.1158/1535-7163.MCT-09-0683

Table 1. Cell growth inhibition effect of HSP90 inhibitors as measured by sulforhodamine B assay in GB cell lines.

IC50 values of NVP-AUY922, its less potent analogs VER-50589 and VER-49009, the natural product radicicol, the ansamycin benzoquinones 17-AAG and 17-DMAG, and the synthetic purine scaffold HSP90 inhibitor BIIB021, in 2 adult (U87MG, SF268) and 2 pediatric (SF188, KNS42) GB lines.

Adult cell lines Pediatric cell lines

IC50 (nM) U87MG SF268 SF188 KNS42
NVP-AUY922 7.8 ± 1.2 6.1 ± 1.5 7.6 ± 2.2 4.8 ± 2.1
VER-50589 57.1 ±20.8 28.0 ± 10.8 54.4 ±14.1 57.6 ± 31.2
VER-49009 587.8 ± 99.3 414.2 ± 20.3 328.3 ± 11.9 681.0 ± 150.4

Radicicol 44.9 ± 4.9 32.4 ± 12.0 35.2 ± 5.7 41.3 ± 21.1

17-AAG 13.9 ± 2.0 12.4 ± 0.6 11.2 ± 0.6 29.7 ± 2.3
17-DMAG 3.7 ± 1.3 3.2 ± 1.4 3.3 ± 0.4 3.1 ± 0.2

BIIB021 75.1 ± 47.0 80.5 ± 39.0 142.1 ± 89.7 109.6 ± 29.9

Values are mean ± SD from at least 3 independent experiments